nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.11.2013 | Review

Incidence and risk of lung cancer in HIV-infected patients

verfasst von: Wenli Hou, Jun Fu, Yuanyuan Ge, Jian Du, Shucheng Hua

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Lung cancer is one of the most common non-AIDS-defining malignancies among HIV-infected patients. The incidence of lung cancer has significantly increased in the HIV-positive population in recent years. The purpose of this study was to summarize the incidence and risk of lung cancer in published population-based studies of people with HIV/AIDS.

Methods

Published literature from PubMed, Embase, the Web of Science, and Google Scholar was retrieved. Sixty-five publications were selected and assessed for the following parameters: research coverage and location; continent; study period; duration of follow-up; lung cancer cases; HIV cases; incidence rate; and overall SIR or adjusted IRR. In addition, the risk of lung cancer was compared based on age, gender, HIV exposure category, CD4 count, and periods with highly active antiretroviral therapy (HAART).

Results

Lung cancer risk was greater among HIV-infected individuals compared with the general population. SIRs or adjusted IRRs were 1.5–3.4 in Europe, 0.7–6.9 in the USA, and 5.0 in Africa. Most, but not all studies did not observe a significant change in the incidence and risk of lung cancer between the pre-HAART and HAART eras. In most studies, the risk of lung cancer was higher among women, younger individuals, and injection drug users (IDUs), but the incidence of lung cancer was higher among men and the elderly. No significant trend in lung cancer risk across CD4 cell count categories was reported among the selected articles.

Conclusion

Our study suggests an increase in the incidence and risk of lung cancer in HIV/AIDS population is worldwide. The effect of HAART on the incidence and risk of lung cancer is in dispute. The risk of lung cancer based on gender differences, especially among females, as well as IDUs, requires further investigation.

Albu E, Reed M, Pathak R, Niazi M, Sivakumar M, Fernandes E, Mailapur RV, Parithivel VS, Gerst PH (2000) Malignancy in HIV/AIDs: a single hospital experience. J Surg Oncol 75(1):11–18PubMedCrossRef

Bain C, Feskanich D, Speizer FE, Thun M, Hertzmark E, Rosner BA, Colditz GA (2004) Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 96(11):826–834PubMedCrossRef

Bedimo R, Chen RY, Accortt NA, Raper JL, Linn C, Allison JJ, Dubay J, Saag MS, Hoesley CJ (2004) Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989–2002. Clin Infect Dis 39(9):1380–1384PubMedCrossRef

Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC (2009) Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 52(2):203–208PubMedCrossRef

Benson MK, Bentley AM (1995) Lung disease induced by drug addiction. Thorax 50(11):1125–1127PubMedCrossRef

Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, Chatelet FP, Katlama C, Charlotte F, Dupont B, Brousse N, Huerre M, Mikol J, Camparo P, Mokhtari K, Tulliez M, Salmon-Ceron D, Boue F, Costagliola D, Raphael M (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98(8):2339–2344PubMedCrossRef

Biggar RJ, Engels EA, Ly S, Kahn A, Schymura MJ, Sackoff J, Virgo P, Pfeiffer RM (2005) Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 39(3):293–299PubMedCrossRef

Borges ÁH, Silverberg MJ, Wentworth D, Grulich AE, Fätkenheuer G, Mitsuyasu R, Tambussi G, Sabin CA, Neaton JD, Lundgren JD (2013) Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS 27(9):1433–1441PubMedCrossRef

Bower M, Powles T, Nelson M, Shah P, Cox S, Mandelia S, Gazzard B (2003) HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 17(3):371–375PubMedCrossRef

Brownson RC, Chang JC, Davis JR (1992) Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology 3(1):61–64PubMedCrossRef

Bruyand M, Thiebaut R, Lawson-Ayayi S, Joly P, Sasco AJ, Mercie P, Pellegrin JL, Neau D, Dabis F, Morlat P, Chene G, Bonnet F (2009) Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis 49(7):1109–1116PubMedCrossRef

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF (2005) Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 104(7):1505–1511PubMedCrossRef

Burns DN, Hillman D, Neaton JD, Sherer R, Mitchell T, Capps L, Vallier WG, Thurnherr MD, Gordin FM (1996) Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 13(4):374–383PubMedCrossRef

Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, Limina R, Castelli F, Quiros-Roldan E (2013) Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy, 1999–2009. HIV Med. doi:10.1111/hiv.12034 PubMed

Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA (2007) Elevated risk of lung cancer among people with AIDS. AIDS 21(2):207–213PubMedCrossRef

Chiu YL, Wang XR, Qiu H, Yu IT (2010) Risk factors for lung cancer: a case–control study in Hong Kong women. Cancer Causes Control 21(5):777–785PubMedCrossRef

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97(6):425–432PubMedCrossRef

Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, Minkoff H, Hessol NA (2002) Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 113(2):91–98PubMedCrossRef

Cooksley CD, Hwang LY, Waller DK, Ford CE (1999) HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 10(12):795–802PubMedCrossRef

Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC (2006) Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 130(5):1326–1333PubMedCrossRef

Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, Fraser S, Agan BK, Wegner S (2009) Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 23(1):41–50PubMedCrossRef

Dal Maso L, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E, Falcini F, Guzzinati S, Zanetti R, Vercelli M, Rezza G (2003) Risk of cancer in persons with AIDS in Italy, 1985–1998. Br J Cancer 89(1):94–100PubMedCrossRef

Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N (2011) Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study. J Int AIDS Soc 14:16PubMedCrossRef

De Matteis S, Consonni D, Pesatori AC, Bergen AW, Bertazzi PA, Caporaso NE, Lubin JH, Wacholder S, Landi MT (2013) Are women who smoke at higher risk for lung cancer than men who smoke? Am J Epidemiol 177(7):601–612PubMedCrossRef

Devesa SS, Bray F, Vizcaino AP, Parkin DM (2005) International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 117(2):294–299PubMedCrossRef

Engels EA (2009) Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS 23(8):875–885PubMedCrossRef

Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD (2006a) Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 24(9):1383–1388PubMedCrossRef

Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ (2006b) Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 20(12):1645–1654PubMedCrossRef

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123(1):187–194PubMedCrossRef

Engsig FN, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, Obel N (2011) Lung cancer in HIV patients and their parents: a Danish cohort study. BMC Cancer 11:272PubMedCrossRef

Estrada O, Romeu J, Gimenez G, Raventos A, Sirera G, Clotet B (1996) Bronchogenic carcinoma in patients with human immunodeficiency virus infection. Med Clin (Barc) 106(17):661–664

Ferraresi A, Calabresi A, Castelli F, Vavassori A, Castelnuovo F, Scalzini A, Torti C, Quiros-Roldan E (2012) Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009. Int J STD AIDS 23(10):753–755PubMedCrossRef

Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, Bouchardy C, Dehler S, Jundt G, Ess S, Bordoni A, Konzelmann I, Frick H, Dal Maso L, Elzi L, Furrer H, Calmy A, Cavassini M, Ledergerber B, Keiser O (2010) Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 103(3):416–422PubMedCrossRef

Franzetti M, Adorni F, Parravicini C, Vergani B, Antinori S, Milazzo L, Galli M, Ridolfo AL (2012) Trends and predictors of non AIDS-defining cancers in men and women with HIV-infection. A Single-Institution Retrospective Study before and after the introduction of HAART. J Acquir Immune Defic Syndr 62(4):414–420

Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC (2008) Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 9(7):649–656PubMedCrossRef

Frisch M, Biggar RJ, Engels EA, Goedert JJ (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285(13):1736–1745PubMedCrossRef

Fu JB, Kau TY, Severson RK, Kalemkerian GP (2005) Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest 127(3):768–777PubMedCrossRef

Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ (2001) Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 154(6):544–556PubMedCrossRef

Grulich AE, Wan X, Law MG, Coates M, Kaldor JM (1999) Risk of cancer in people with AIDS. AIDS 13(7):839–843PubMedCrossRef

Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM (2002) Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16(8):1155–1161PubMedCrossRef

Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E, Costagliola D (2009) Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 10(12):1152–1159PubMedCrossRef

Harris RE, Zang EA, Anderson JI, Wynder EL (1993) Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 22(4):592–599PubMedCrossRef

Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, Costagliola D (2003) Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21(18):3447–3453PubMedCrossRef

Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S (2007) The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 165(10):1143–1153PubMedCrossRef

Irwin LE, Begandy MK, Moore TM (1984) Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome. Ann Intern Med 100(1):158PubMedCrossRef

Jee SH, Samet JM, Ohrr H, Kim JH, Kim IS (2004) Smoking and cancer risk in Korean men and women. Cancer Causes Control 15(4):341–348PubMedCrossRef

Johnson CC, Wilcosky T, Kvale P, Rosen M, Stansell J, Glassroth J, Reichman L, Wallace J, Markowitz N, Thompson JE, Hopewell P (1997) Cancer incidence among an HIV-infected cohort. Pulmonary Complications of HIV Infection Study Group. Am J Epidemiol 146(6):470–475PubMedCrossRef

Karp J, Profeta G, Marantz PR, Karpel JP (1993) Lung cancer in patients with immunodeficiency syndrome. Chest 103(2):410–413PubMedCrossRef

Kiertiburanakul S, Likhitpongwit S, Ratanasiri S, Sungkanuparph S (2007) Malignancies in HIV-infected Thai patients. HIV Med 8(5):322–323PubMedCrossRef

Kirk GD, Merlo C, O’Driscoll P, Mehta SH, Galai N, Vlahov D, Samet J, Engels EA (2007) HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 45(1):103–110PubMedCrossRef

Krishnan S, Schouten JT, Jacobson DL, Benson CA, Collier AC, Koletar SL, Santana J, Sattler FR, Mitsuyasu R (2011) Incidence of non-AIDS-defining cancer in antiretroviral treatment-naive subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis. Oncology 80(1–2):42–49PubMedCrossRef

Lavole A, Chouaid C, Baudrin L, Wislez M, Raguin G, Pialoux G, Girard PM, Milleron B, Cadranel J (2009) Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer 65(3):345–350PubMedCrossRef

Lee T, Gany F (2012) Cooking oil fumes and lung cancer: a review of the literature in the context of the U.S. population. J Immigr Minor Health 15(3):646–652

Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, Anastos K, Minkoff H, Orenstein J, Dominguez G, Watts DH (2010) HIV as a risk factor for lung cancer in women: data from the Women’s Interagency HIV Study. J Clin Oncol 28(9):1514–1519PubMedCrossRef

Li Y, Law M, McDonald A, Correll P, Kaldor JM, Grulich AE (2002) Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus. Am J Epidemiol 155(2):153–158PubMedCrossRef

Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR (2010) Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health 100(10):1896–1903PubMedCrossRef

Long JL, Engels EA, Moore RD, Gebo KA (2008) Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS 22(4):489–496PubMedCrossRef

Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA (2003) Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32(5):527–533PubMedCrossRef

Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118(4):985–990PubMedCrossRef

Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d’Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 352(9142):1725–1730PubMedCrossRef

Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, Francioli P, D’Arminio Monforte A, Fox Z, Lundgren JD (2002) Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 16(12):1663–1671PubMedCrossRef

Monfardini S, Vaccher E, Pizzocaro G, Stellini R, Sinicco A, Sabbatani S, Marangolo M, Zagni R, Clerici M, Foa R et al (1989) Unusual malignant tumours in 49 patients with HIV infection. AIDS 3(7):449–452PubMedCrossRef

Oh MD, Park SW, Kim HB, Kim US, Kim NJ, Choi HJ, Shin DH, Lee JS, Choe K (1999) Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea. Clin Infect Dis 29(6):1524–1528PubMedCrossRef

Overland ES, Nolan AJ, Hopewell PC (1980) Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities. Am J Med 68(2):231–237PubMedCrossRef

Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338(13):853–860PubMedCrossRef

Parker MS, Leveno DM, Campbell TJ, Worrell JA, Carozza SE (1998) AIDS-related bronchogenic carcinoma: fact or fiction? Chest 113(1):154–161PubMedCrossRef

Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT (2008) Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 148(10):728–736PubMedCrossRef

Petoumenos K, van Leuwen MT, Vajdic CM, Woolley I, Chuah J, Templeton DJ, Grulich AE, Law MG (2013) Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD). HIV Med 14(2):77–84PubMedCrossRef

Petruckevitch A, Del Amo J, Phillips AN, Stephenson JM, Johnson AM, De Cock KM (1999) Risk of cancer in patients with HIV disease. London African HIV/AIDS Study Group. Int J STD AIDS 10(1):38–42PubMedCrossRef

Phelps RM, Smith DK, Heilig CM, Gardner LI, Carpenter CC, Klein RS, Jamieson DJ, Vlahov D, Schuman P, Holmberg SD (2001) Cancer incidence in women with or at risk for HIV. Int J Cancer 94(5):753–757PubMedCrossRef

Pinto Neto LF, Milanez Mda C, Golub JE, Miranda AE (2012) Malignancies in HIV/AIDS patients attending an outpatient clinic in Vitoria, State of Espirito Santo, Brazil. Rev Soc Bras Med Trop 45(6):687–690PubMedCrossRef

Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Moller H, Bower M (2009) Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 27(6):884–890PubMedCrossRef

Prescott E, Osler M, Hein HO, Borch-Johnsen K, Lange P, Schnohr P, Vestbo J (1998) Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology 9(1):79–83PubMedCrossRef

Prosperi MC, Cozzi-Lepri A, Castagna A, Mussini C, Murri R, Giacometti A, Torti C, Costantini A, Narciso P, Ghinelli F, Antinori A, d’Arminio Monforte A (2010) Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. Clin Infect Dis 50(9):1316–1321PubMedCrossRef

Rabkin CS, Yellin F (1994) Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 86(22):1711–1716PubMedCrossRef

Ramirez-Marrero FA, Smit E, De La Torre-Feliciano T, Perez-Irizarry J, Miranda S, Cruz M, Figueroa-Valles NR, Crespo CJ, Nazario CM (2010) Risk of cancer among Hispanics with AIDS compared with the general population in Puerto Rico: 1987–2003. P R Health Sci J 29(3):256–264PubMed

Ricaurte JC, Hoerman MF, Nord JA, Tietjen PA (2001) Lung cancer in HIV-infected patients: a one-year experience. Int J STD AIDS 12(2):100–102PubMedCrossRef

Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB (1993) Are female smokers at higher risk for lung cancer than male smokers? A case–control analysis by histologic type. Am J Epidemiol 138(5):281–293PubMed

Ruiz M (2010) Lung cancer in HIV-infected patients: the experience of an urban clinic. J Int Assoc Physicians AIDS Care (Chic) 9(4):214–217CrossRef

Ryberg D, Hewer A, Phillips DH, Haugen A (1994) Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 54(22):5801–5803PubMed

Santos Gonzalez J, Velasco Garrido JL, Rivero Roman A, Marquez Solero M, Abarca Costalago M (1996) Cancer of the lung in patients with HIV infection. Rev Clin Esp 196(9):603–605PubMed

Seaberg EC, Wiley D, Martinez-Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP (2010) Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 116(23):5507–5516PubMedCrossRef

Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L, Ballarini P, Pezzotti P, Smacchia C, Pesce A, Ippolito G, Franceschi S, Rezza G (2000) Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 14(5):553–559PubMedCrossRef

Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S (2007) Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 43(14):2117–2123PubMedCrossRef

Shebl FM, Engels EA, Goedert JJ, Chaturvedi AK (2010) Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr 55(3):375–379PubMedCrossRef

Sherman CB, Hudson LD, Pierson DJ (1987) Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers. Chest 92(6):1085–1087PubMedCrossRef

Shiels MS, Cole SR, Mehta SH, Kirk GD (2010a) Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr 55(4):510–515PubMedCrossRef

Shiels MS, Pfeiffer RM, Engels EA (2010b) Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 153(7):452–460PubMedCrossRef

Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, Brown ST, Goulet J, Butt AA, Crystal S, Rimland D, Rodriguez-Barradas M, Gibert C, Park LS, Crothers K (2012) HIV as an independent risk factor for incident lung cancer. AIDS 26(8):1017–1025PubMedCrossRef

Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI (2007) Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 21(14):1957–1963PubMedCrossRef

Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP Jr, Towner WJ, Abrams DI (2009) HIV infection and the risk of cancers with and without a known infectious cause. AIDS 23(17):2337–2345PubMedCrossRef

Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Dubrow R, Quesenberry CP Jr, Neugebauer RS, Abrams DI (2011) HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 20(12):2551–2559PubMedCrossRef

Simard EP, Pfeiffer RM, Engels EA (2010) Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med 170(15):1337–1345PubMedCrossRef

Simard EP, Pfeiffer RM, Engels EA (2011) Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 117(5):1089–1096PubMedCrossRef

Simard EP, Shiels MS, Bhatia K, Engels EA (2012) Long-term cancer risk among people diagnosed with AIDS during childhood. Cancer Epidemiol Biomarkers Prev 21(1):148–154PubMedCrossRef

Spagnuolo V, Galli L, Salpietro S, Gianotti N, Guffanti M, Cossarini F, Bigoloni A, Cinque P, Bossolasco S, Travi G, Fumagalli L, Lazzarin A, Castagna A (2012) Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies. Int J Cancer 130(12):2990–2996PubMedCrossRef

Sridhar KS, Flores MR, Raub WA Jr, Saldana M (1992) Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest 102(6):1704–1708PubMedCrossRef

Srisawat N, Avihingsanon A, Praditpornsilpa K, Jiamjarasrangsi W, Eiam-Ong S, Avihingsanon Y (2008) A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy. Transplant Proc 40(8):2677–2679PubMedCrossRef

van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, Grulich AE (2009) Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 23(16):2183–2190PubMedCrossRef

Vogel M, Friedrich O, Luchters G, Holleczek B, Wasmuth JC, Anadol E, Schwarze-Zander C, Nattermann J, Oldenburg J, Sauerbruch T, Rockstroh JK, Spengler U (2011) Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence. Eur J Med Res 16(3):101–107PubMedCrossRef

Titel: Incidence and risk of lung cancer in HIV-infected patients
verfasst von: Wenli Hou
Jun Fu
Yuanyuan Ge
Jian Du
Shucheng Hua
Publikationsdatum: 01.11.2013
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2013
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-013-1477-2

Springer Medizin

Incidence and risk of lung cancer in HIV-infected patients

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2013

Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis

Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series

May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy?

Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung

Loss of chromosome 4 correlates with better long-term survival and lower relapse rate after R0-resection of colorectal liver metastases

Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie